GlassScriptPhysician profile
William M Gill
NPI 1932171139
$14,141.55
in general payments reported to CMS, 2019-2025
48 companies · $2,141 in 2025
The $2,141 reported for 2025 was more than what 77% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,036 · 2020: $1,579 · 2021: $1,936 · 2022: $2,376 · 2023: $2,130 · 2024: $1,943 · 2025: $2,141.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,025 · Education: $189.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,025.11 |
| Education | $188.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $3,554.43 | 2019-2025 | Fasenra, Tezspire, Airsupra |
| Glaxosmithkline, LLC. | $2,743.98 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $773.49 | 2019-2025 | Ofev |
| Insmed, INC. | $686.42 | 2019-2025 | Arikayce, Brinsupri |
| Jazz Pharmaceuticals INC. | $559.26 | 2019-2025 | Xywav |
| Mallinckrodt Hospital Products INC. | $511.48 | 2020-2025 | Acthar |
| Grifols USA, LLC | $379.38 | 2019-2025 | Prolastin-C Liquid, Xembify |
| Inogen, INC. | $354.61 | 2022-2025 | Inogen |
| Regeneron Healthcare Solutions, INC. | $343.20 | 2019-2025 | Dupixent |
| Abbvie INC. | $308.78 | 2021-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $291.51 | 2021-2025 | Glassia |
| Mylan Specialty L.P. | $287.85 | 2019-2024 | Yupelri |
| Genzyme Corporation | $273.61 | 2019-2025 | |
| Pulmonx Corporation | $219.92 | 2023-2025 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Zephyr Endobronchial Valve |
| Fisher & Paykel Healthcare INC | $218.85 | 2020-2022 |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $210.38 | 2022-2025 | Tezspire |
| Actelion Pharmaceuticals US, INC. | $201.67 | 2020-2025 | Opsumit, Uptravi |
| Novartis Pharmaceuticals Corporation | $187.83 | 2020-2025 | |
| Genentech USA, INC. | $172.61 | 2019-2024 | Xolair |
| Philips North America LLC | $172.46 | 2019-2025 | Vest Therapy Und, (Ak6) Vest Therapy |
| Merck Sharp & Dohme LLC | $164.84 | 2020-2024 | Recarbrio, Zerbaxa, Dificid |
| Intuitive Surgical, INC. | $159.46 | 2023 | Da Vinci Surgical System |
| Inspire Medical Systems, INC. | $120.76 | 2023-2025 | Inspire |
| Alexion Pharmaceuticals, INC. | $118.02 | 2019-2022 | |
| Harmony Biosciences LLC | $110.48 | 2025 | |
| Shionogi INC | $93.87 | 2021-2024 | Fetroja |
| Allergan, INC. | $93.17 | 2019-2020 | |
| Portola Pharmaceuticals, LLC | $91.19 | 2019-2020 | |
| Gilead Sciences, INC. | $85.56 | 2019-2022 | |
| Electromed, INC. | $79.17 | 2019-2024 | Smartvest |
| Baxter Healthcare | $60.46 | 2022-2023 | Hillrom - Life 2000 Ventilation System |
| Axsome Therapeutics, INC. | $57.18 | 2025 | Sunosi |
| Csl Behring | $51.76 | 2019-2025 | Kcentra |
| Advanced Respiratory, INC | $44.89 | 2021 | |
| Viatris Specialty LLC | $44.29 | 2025 | Yupelri |
| Ani Pharmaceuticals, INC. | $42.67 | 2023 | Purified Cortrophin Gel |
| Lilly USA, LLC | $42.39 | 2025 | Mounjaro, Zepbound |
| Novo Nordisk INC | $37.14 | 2021 | |
| Idorsia Pharmaceuticals US INC | $32.37 | 2022-2023 | Quviviq |
| Vapotherm INC | $26.25 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $25.61 | 2019 | |
| United Therapeutics Corporation | $23.81 | 2022 | |
| Boston Scientific Corporation | $22.92 | 2022 | |
| Circassia INC. | $18.54 | 2019 | |
| Verona Pharma, INC. | $15.54 | 2025 | Ohtuvayre |
| Nabriva Therapeutics, Plc | $13.99 | 2020 | |
| Sunovion Pharmaceuticals INC. | $13.50 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Gill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.